Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Article Menu
Export Article
More by Authors Links
Article Data
- Views 522
- Dowloads 114
Case Reports
Open AccessAdvanced stage yolk sac ovarian tumour: clinical approach with cytoreductive surgery upfront
Advanced stage yolk sac ovarian tumour: clinical approach with cytoreductive surgery upfront
1Medical Oncology Department, Centro Hospitalar São João, Porto, Portugal, Spain
2Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain
3Department of Pathology, MD Anderson Cancer Center, Madrid, Spain
4Department of Gynecology, MD Anderson Cancer Center, Madrid, Spain
*Corresponding Author(s): I. Pimentel E-mail: immpsp@gmail.com
Abstract
The authors report the case of a 21-year-old woman that presented a Pseudo Meigs’ syndrome, secondary to a pure endodermal sinus tumour (yolk sac tumour). Fine needle aspiration biopsy was compatible with high-grade carcinoma and the alpha fetoprotein (αFP) was at 13,185 U/ml. Cytoreductive surgery was performed, followed by bleomycin, etoposide, and cisplatin (BEP) chemotherapy.
Keywords
Yolk sac ovarian tumour; Endodermal sinus ovarian tumour.
Cite and Share
I. Pimentel,A. González Martín,R. Bratos,R. Marquez,G. Toledo,L. Chiva. Advanced stage yolk sac ovarian tumour: clinical approach with cytoreductive surgery upfront. European Journal of Gynaecological Oncology. 2017. 38(2);311-313.
References
[1] DeVita V., Lawrence T., Rosenberg S.: “Principles and Practice of Oncology”. 9thed. Philadelphia: Lippincott Williams & Wilkins, 2011 104, 1386.
[2] Fujita M., Inoue M., Tanizawa O., Minagawa J., Yamada T., Tani T.: “Retrospective review of 41 patients with endodermal sinus tumor of the ovary”. Int. J. Gynecol Cancer, 1993, 3, 329.
[3] Wu P.C., Huang R.L., Lang J.H., Huang H.F., Lian L.J., Tang M.Y.: “Treatment of malignant ovarian germ cell tumors with preservation of fertility: a report of 28 cases”. Gynecol. Oncol., 1991, 40, 2.
[4] Dällenbach P., Bonnefoi H., Pelte M.F., Vlastos G.: “Yolk sac tumours of the ovary: an update”. Eur. J. Surg. Oncol., 2006, 32, 1063.
[5] Berman M.L.: “Future directions in the surgical management of ovarian cancer”. Gynecol. Oncol., 2003, 90, 33.
[6] Pectasides D., Pectasides E., Kassanos D.: “Germ cell tumors of the ovary” Cancer Treat. Rev., 2008, 34, 427.
[7] Kazanov L., Ander D.S., Enriquez E., Jaggi F.M.: “Pseudo-Meigs’ syndrome”. Am. J. Emerg. Med., 1998, 16, 404.
[8] Williams S., Blessing J.A., Liao S.Y., Ball H., Hanjani P.: “Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide and bleomycin: a trial of the Gynecology Oncology Group”. J. Clin. Oncol., 1994, 12, 701
[9] Lee C.W., Song M.J.., Park S.T., Ki E.Y., Lee S.J., Lee K.H., et al.: “Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: A retrospective study of single institution”. World J. Surg, Oncol., 2011, 9, 123.
[10] Nawa A., Obata N., Kikkawa F., Kawai M., Nagasaka T., Goto S., et al.: “Prognostic factors of patients with yolk sac tumors of the ovary”. Am. J. Obstet. Gynecol., 2001, 184, 1182.
[11] Kawai M., Kano T., Furuhashi Y., Mizuno K., Nakashima N., Hattori S.E., et al.: “Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 cases”. Cancer, 1991, 67, 184.
[12] Gershenson D.M., Morris M., Cangir A., Kavanagh J.J, Stringer C.A., Edwards C.L., et al.: “Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin”. J. Clin. Oncol., 1990, 8, 715.
[13] Gershenson D.M.: “Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors”. J. Clin. Oncol., 1988, 6, 270.
[14] Mitchell P.L., Al-Nasiri N., A’Hern R., Fisher C., Horwich A., Pinkerton C.R., et al.: ” Treatment of non-dysgerminomatous ovarian germ cell tumors: an analysis of 69 cases”. Cancer, 1999, 85, 2232.
Abstracted / indexed in
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.
Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.
JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.
Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.
BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Submission Turnaround Time
Conferences
Top